svod2009 smart needle
TRANSCRIPT
Dmitry Shpakov
Igloptika Ltd.tel.: +7 (911) 990-90-66
Skype: igloptika
«Smart Needle»
«Injections must be safe!»
Epidural Space
Pain
Childbirth anesthesia
Russia USA
Loss from one complication $2,3K $85K
Number of operations, annual 1,5M 3,2M
Complications rate 1%
Number of Complications 15 000 32 000
Loss $34,5M $2,72B
Solution
Smart Needle
•Easy to use•Safe•Can record data
Unique patented technology
Patents of Russian Federation
PCT
2010
Patent №2243002 Patent №2245674
Competitors
Direct:Pressure control (Milestone Scientific)
Substitute: Manual methods Ultrasound observation X-rays observation
All have technical and cost disadvantages
Smart Needle applications
SmartNeedle
Epiduralanesthesia:
UrologyGynecologyChildbirthOther surgery
Catheterinsertions:
VeinsArtery
Direct needle access:
InjectionsSampling
Market Size
Target Markets
RussiaUSAEuropeChina
Russia USA
Epidural anesthesia $350M $600M
Direct needle access $100M $300M
Catheter insertions $150M $300M
TOTAL $600M $1.2B
Business-model
OEMs
Smart Needle USAProduction, marketing, sales, support
Insurance companies PhysiciansHospitals, cliniks
SN – Smart Needle.
Igloptika, Ltd.R&D
Distributors
$SN
SN
SN
SN
Marketing
$
$Feed-back
Feed-back
Business-model
Newly established US-company will manufacture Smart Needle device and disposable needles.
Main revenue generation stream is from repeat sells of disposable needles.
Marketing will be done by educating hospitals, physicians and insurance companies about Smart Needle value and decreasing medical accidents.
Team
Dmitry Shpakov – CEODesigning of optical devices (6 years),executive management.
Svjatoslav Latyev – CTO PhD, Professor, Chief designer
Vladimir Volchkov – Med AdviserPhD, Professor,Chief Anesthesiologist of North-West region of Russia
Sergey Poduzov – Biz Adviser MIBA, 6 years in corporate finance
Michael Shpakov - CIOPhD, 16 years in softwaredevelopment
Current status & Roadmap
Prototype 2009
Testing prototype 2009
Pre-production model 2010
PCT Patent 2010
FDA Approval 2011-2013
Today
Sertification in Russia 2011
1-st Round
2-nd Round
The Offer
1 st round: $2M– PCT Patent– Pre-production model– Sertification in Russia
•2 nd round: $10M– FDA Approval– Star CEO– Business team
Share:Founders - 55%Investor - 45%
Share:Foundres - 10%Investor - 45%
Experienced team Unique patented technology Market estimated over $1B Looking for $2M We are saving human health!
Contact us: [email protected]
«Smart Needle»
THANK YOU!